Alkermes Plc (ALKS)
Alkermes Market Cap : 5.764B for Feb. 11, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Avadel Pharmaceuticals Plc | 2.113B |
| Krystal Biotech, Inc. | 7.906B |
| CorMedix, Inc. | 585.40M |
| Amicus Therapeutics, Inc. | 4.415B |
| Jazz Pharmaceuticals Plc | 10.10B |
Market Cap Related Metrics
| PE Ratio | 17.27 |
| PS Ratio | 3.856 |
| PEG Ratio | 5.857 |
| Price to Book Value | 3.325 |
| Price to Free Cash Flow | 11.95 |
| Price | 34.91 |
| Earnings Yield | 5.79% |
| PEGY Ratio | 5.857 |
| Operating PE Ratio | 16.36 |
| Normalized PE Ratio | 17.24 |